Science

AddToAny

Google+ Facebook Twitter Twitter

Medical eponyms PT 3 (2): Guido Fanconi

This is the second instalment on Guido Fanconi in a series of short biographies of persons whose names are directly used for diseases, conditions, syndromes or tests familiar to those working in clinical pathology labs.

In 1931, Fanconi reported a child with glycosuria and albuminuria, in addition to rickets and dwarfism. Two years later, a similar case of a five-year-old child with short stature, glycosuria, “abundant” urine, low serum phosphate and rickets was reported by the Italian paediatrician Giovanni de Toni. In 1934 the French paediatrician Robert Debre reported an 11-year-old girl with rickets, glycosuria and increased organic acid excretion. In 1936 Fanconi suggested that the organic acids were amino acids and recognised the similarities in these reports and added two more cases and elaborated on the biochemistry of this collection of symptoms. In 1943 McCune and colleagues produced a comprehensive description of the clinical and chemical features of renal Fanconi syndrome (RFS) with a literature review of cases to that date and designated the condition as the Fanconi syndrome. A study in 1946 by Charles Dent at University College Hospital, London used paper partition two-way chromatography to identify the amino acids, as a generalised renal aminoaciduria in a 34-year-old man with RFS. In 1949 Fanconi, working with German physician Horst Bickel in Zurich, reported a combination of findings in a child including urine aminoaciduria, glycosuria and rickets, but significantly glycogen deposition, and was designated as glycogen storage disease type XI. However, it is now regarded as a defect of carbohydrate transport and cited as Fanconi Bickel syndrome.

During the following two decades, a number of inherited diseases and deposition conditions associated with renal tubular dysfunction displayed the biochemical hallmarks of RFS.

Please click here to read the full article.

 

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top